Drug profile · INN
lorazepam
LORAZEPAM
lorazepam (LORAZEPAM) is a gaba-a receptor; anion channel positive allosteric modulator. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
Drug details — lorazepam
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 1
- Data quality
- 0.89
Quick answer
lorazepam (LORAZEPAM) is a gaba-a receptor; anion channel positive allosteric modulator. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
GABA-A receptor; anion channel positive allosteric modulator
Primary target: GABA-A receptor; anion channel
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is lorazepam?
lorazepam (LORAZEPAM) is a gaba-a receptor; anion channel positive allosteric modulator. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for lorazepam?
LORAZEPAM is a marketed brand name for lorazepam. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of lorazepam?
lorazepam has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.